While research into glutathione is promising for various reasons, it's still early days
Mol Immunol
GHK-Cu is a wellness peptide, not a cure for any disease, and outcomes vary from person to person
Thats more than I typically spend on groceries in a month, but less than what I spend on groceries and eating out combined
Illustratively, BPC 157 may interfere with NO-system activities (Sikiric et al., 2014) and counteract harmful events, arising from either NO-blockade (L-NAME-application) or L-arginine (NOS-substrate-application) (Sikiric et al., 2014)
Some patients may experience transient changes in blood pressure, though long-term cardiovascular outcomes studies have generally shown beneficial or neutral effects of GLP-1 receptor agonists on cardiovascular events